Literature DB >> 21710204

PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication.

Il-Hyun Park1, Kyung-Won Baek, Eun-Young Cho, Byung-Yoon Ahn.   

Abstract

Interferon-α (IFN-α) inhibits the replication of hepatitis B virus (HBV) in vivo and in vitro, but the molecular mechanism of this inhibition has been elusive. We found that while HBV replication in transfected human hepatoma Huh-7 cell was severely inhibited by IFN-α treatment as reported previously, this inhibition was markedly impaired in the cell in which the expression of IFN-inducible, double-stranded RNA-dependent protein kinase (PKR) was stably and specifically suppressed through RNA-interference. Intracellular level of viral capsids was down-regulated likewise in a PKR-dependent manner, whereas that of HBV transcripts including the viral RNA pregenome was not affected by IFN-α treatment. Ectopic expression of PKR also resulted in the reduction of viral capsids with concomitant increase of phosphorylated eIF2α. These results suggested that PKR functions as a key mediator of IFN-α in opposing HBV replication, most likely through the inhibition of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710204      PMCID: PMC3887671          DOI: 10.1007/s10059-011-1059-6

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  22 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

2.  Inhibition of hepatitis B virus replication by interferon requires proteasome activity.

Authors:  Michael D Robek; Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.

Authors:  A Rang; S Günther; H Will
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

4.  Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Authors:  Chunxiao Xu; Haitao Guo; Xiao-Ben Pan; Richeng Mao; Wenquan Yu; Xiaodong Xu; Lai Wei; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

5.  Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.

Authors:  Valérie Pasquetto; Stefan F Wieland; Susan L Uprichard; Marco Tripodi; Francis V Chisari
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.

Authors:  Luca G Guidotti; Amber Morris; Heike Mendez; Rick Koch; Robert H Silverman; Bryan R G Williams; Francis V Chisari
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells.

Authors:  Kazuyuki Ohata; Tatsuki Ichikawa; Kazuhiko Nakao; Masaya Shigeno; Daisuke Nishimura; Hiroki Ishikawa; Keisuke Hamasaki; Katsumi Eguchi
Journal:  FEBS Lett       Date:  2003-10-23       Impact factor: 4.124

8.  Transcriptional and posttranscriptional control of hepatitis B virus gene expression.

Authors:  Susan L Uprichard; Stefan F Wieland; Alana Althage; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

9.  Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.

Authors:  Man-Young Cha; Chang-Myeong Kim; Young-Min Park; Wang-Shick Ryu
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.

Authors:  Y Hayashi; K Koike
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

View more
  14 in total

1.  Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity.

Authors:  Jianhua Li; Kuancheng Liu; Yang Liu; Yan Xu; Fei Zhang; Huijuan Yang; Jiangxia Liu; Tingting Pan; Jieliang Chen; Min Wu; Xiaohui Zhou; Zhenghong Yuan
Journal:  Nat Immunol       Date:  2013-07-07       Impact factor: 25.606

2.  TGF-β and iron differently alter HBV replication in human hepatocytes through TGF-β/BMP signaling and cellular microRNA expression.

Authors:  Sun O Park; Mukesh Kumar; Sanjeev Gupta
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

3.  Activation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus.

Authors:  Shilei Zhang; Yingjie Sun; Hongjun Chen; Yabin Dai; Yuan Zhan; Shengqing Yu; Xusheng Qiu; Lei Tan; Cuiping Song; Chan Ding
Journal:  Virol J       Date:  2014-03-31       Impact factor: 4.099

Review 4.  Control of Hepatitis B Virus by Cytokines.

Authors:  Yuchen Xia; Ulrike Protzer
Journal:  Viruses       Date:  2017-01-20       Impact factor: 5.048

Review 5.  Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.

Authors:  Ana Maria Ortega-Prieto; Marcus Dorner
Journal:  Vaccines (Basel)       Date:  2017-09-01

6.  Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection.

Authors:  Yong Li; Chuanlong Zhu; Faxi Wang; Tiantian Zhu; Jun Li; Shufeng Liu; Fei Xiao
Journal:  Mediators Inflamm       Date:  2016-12-18       Impact factor: 4.711

7.  OASL1 Traps Viral RNAs in Stress Granules to Promote Antiviral Responses.

Authors:  Ji-Seon Kang; Yune-Sahng Hwang; Lark Kyun Kim; Sujung Lee; Wook-Bin Lee; Jeongsil Kim-Ha; Young-Joon Kim
Journal:  Mol Cells       Date:  2018-02-21       Impact factor: 5.034

8.  Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.

Authors:  Ivan Hirsch; Jan Weber; Vaclav Janovec; Jan Hodek; Kamila Clarova; Tomas Hofman; Pavel Dostalik; Jiri Fronek; Jaroslav Chlupac; Laurence Chaperot; Sarah Durand; Thomas F Baumert; Iva Pichova; Barbora Lubyova
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

9.  Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.

Authors:  Małgorzata Krześniak; Artur Zajkowicz; Agnieszka Gdowicz-Kłosok; Magdalena Głowala-Kosińska; Barbara Łasut-Szyszka; Marek Rusin
Journal:  Cell Signal       Date:  2020-02-04       Impact factor: 4.315

10.  2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication.

Authors:  Hui Ma; Xing-Liang Zhao; Xue-Yan Wang; Xing-Wang Xie; Jin-Chao Han; Wen-Li Guan; Qin Wang; Lin Zhu; Xiao-Ben Pan; Lai Wei
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.